For over 20 years, our diverse team of medical professionals has provided consistent, high-quality research in a professional and ethical manner through collaboration with multi-national pharmaceutical, biotechnology and CRO companies on Phase I-IV clinical trials.

Cedar Crosse Research Center has conducted more than 450+ clinical trials across a wide range of therapeutic areas. Our board-certified investigators, experienced study coordinators and support staff are strictly compliant with Good Clinical Practice (GCP) and the changing dynamics of medical technology and clinical research. Using cost-effective management techniques, we yield superior quality data to progress studies faster for sponsor timelines and regulatory approval.

Clinical Expertise Experience


The year Dr. Danny Sugimoto founded Cedar Crosse Research Center to make meaningful improvements in the lives of others through clinical research trials.


Number of clinical trials completed with a multi-specialty therapeutic expertise including diabetes, hypertension, obesity, COPD, migraines, hyperlipidemia, etc.


Average cycle time in days from IRB submittal to IRB approval.

Principles of research


A personalized, patient centered perspective in all clinical tasks.


Strictly adhering to GCP and FDA regulatory procedures to quality date collections.


Uniting with patients to improve lives.

Randomization Rate

General medicine

  • Bioavailability/Bioequivalence
  • Biosimilar/Bioidentical
  • Coronary Artery Disease
  • Diabetes type I & II
  • Heart Disease
  • Heartburn/GERD
  • Hypercholesterolemia
  • Hypertension
  • Hypertriglyceridemia
  • Insulin Sensitivity
  • Metabolic Syndrome
  • Nutrition
  • Obesity

Neurology & Psychiatry

  • Alzheimer’s Disease and related dementia
  • Cognitive Function
  • Insomnia
  • Migraine
  • Obesity
  • Sexual Dysfunction (Male)
  • Smoking Cessation


  • COPD
  • Asthma
  • Sleep Disorders

Pain disorders

  • Chronic Low Back Pain
  • Chronic Regional Pain Syndrome
  • Fibromyalgia